HCPCS Level II · Drugs administered other than oral method
J9183Gemcitabine intravesical system, 225 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J9183
J9183 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing gemcitabine intravesical system, 225 mg.
It was added to HCPCS effective 04/01/2026.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Gemcitabine intravesical sys
- Date added
- 04/01/2026
- Action effective
- 04/01/2026
- BETOS
- O1D
Related J91xx codes
- J9100Injection, cytarabine, 100 mg
- J9118Injection, calaspargase pegol-mknl, 10 units
- J9119Injection, cemiplimab-rwlc, 1 mg
- J9120Injection, dactinomycin, 0.5 mg
- J9130Dacarbazine, 100 mg
- J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145Injection, daratumumab, 10 mg
- J9150Injection, daunorubicin, 10 mg
- J9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155Injection, degarelix, 1 mg
- J9161Injection, denileukin diftitox-cxdl, 1 mcg
- J9171Injection, docetaxel, 1 mg
Common questions about J9183
Is HCPCS J9183 still valid?
- Yes. J9183 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J9183?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.